Search PubMed⌕ Search

Biomedical subjects

E R Laws

Publications and source records attributed to E R Laws.

At least 289 records · Page 16Linked to original sources
PubMed1975

Transcutaneous electrical stimulation for treatment of chronic pain: a preliminary report.

Two hundred thirty patients received transcutaneous electrical stimulation for intractable pain. Although almost 60% of the patients noted some degree of pain relief, slightly less than half (43%) of those tested decided to purchase a stimulator. About 20% of those who bought stimulators did not continue to obtain pain relief from transcutaneous electrical stimulation during the two to six month follow-up period. Many others noted a decrease in the amount of pain relief they obtained.

Adolescent↗
PubMed1968

Field study of the safety of abate for treating potable water and observations on the effectiveness of a control programme involving both abate and malathion.

Abate is a larvicide for Aedes aegypti, a vector of yellow fever, dengue, and haemorrhagic fever. It is less toxic than malathion or DDT. Tests in human volunteers had previously indicated it would be safe to add to drinking-water where the mosquito often breeds.In a 19-month test in Puerto Rico, Abate was added to the drums and cisterns in which a community of about 2000 persons stored their drinking-water. This use of Abate and other insecticidal measures (malathion spraying) gradually achieved control of A. aegypti during the first 4 months of treatment and control was maintained thereafter although the test area was surrounded by active breeding-sites. There was no accumulation of Abate in the water in spite of monthly additions of the compound. With minor exceptions, residents readily accepted this use of Abate. Careful surveillance failed to reveal any illness or significant side-effects attributable to measures adopted in the control programme. Abate is considered safe for full-scale field use according to directions.

Aedes↗
PubMedDate not supplied

A craniofacial approach to advanced recurrent cancer of the central face.

Recurrent penetrating midface cancer results from basal cell carcinoma, squamous cell carcinoma, adenocystic carcinoma, and chondrogenic and osteogenic sarcoma. In the past, surgical resection frequently resulted in meningitis. A combined neurosurgical and plastic surgical craniofacial approach has been used for total resection of these lesions. The floor of the anterior cranial fossa has been reconstructed with an extended glabellar flap incorporating a forehead Z-plasty. Over the past 2-and-a-half years, 10 patients have been operated on successfully. Five cases with a follow-up of over 2 years are presented.

Aged↗